Dentsply Sirona Q4 revenue rises 6.2%

DENTSPLY SIRONA

26/02/2026 21:25

Overview

Dental products maker's Q4 2025 revenue rose 6.2%

Q4 adjusted EPS was $0.27, marginally higher from last year

Company announced restructuring to redirect $120 mln annually into growth initiatives

Outlook

Company expects FY 2026 net sales between $3.5 bln and $3.6 bln

Company anticipates FY 2026 adjusted EPS of $1.40 to $1.50

Dentsply Sirona eliminates dividend to focus on debt retirement and share repurchases

Result Drivers

GOODWILL AND INTANGIBLE IMPAIRMENTS - Q4 net loss driven by $144 mln impairments, attributed to lower-than-expected volumes in Orthodontic and Implant Solutions and Connected Technology Solutions

Company press release: ID:nGNX1ny7nB

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
Beat
$3.68 bln
$3.64 bln (16 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 12 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for DENTSPLY SIRONA Inc is $12.25, about 4.3% below its February 25 closing price of $12.80

The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 6 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)